Specifically, NKX2-8 interacts with HDAC1 to form a complex that suppresses PTHrP transcription in breast cancer cells with no bone metastasis, while silencing NKX2-8 could eliminate its inhibition of bone metastasis. The gene discussed is HDAC1; the disease is breast cancer.